DXC Technology
Runs and modernizes complex IT estates for global enterprises and public-sector organizations.
Something off on this page? Send us feedback.
Profile
Sells consulting, engineering, infrastructure, managed applications, cybersecurity and insurance services. Its operating model joins the 2017 CSC–HPE Enterprise Services combination with international delivery for enterprise and public-sector clients.
Formed from CSC and HPE Enterprise Services in 2017, the company operates and modernizes complex IT estates for global enterprises and public-sector organizations. Built through a transaction rather than a founder-led launch, its remit centers on helping those organizations run current systems while changing them. Its work spans business-process services, cloud and infrastructure, cybersecurity, enterprise applications, managed applications, modernization and workplace services.
Consulting & Engineering Services, Global Infrastructure Services and Insurance are the reportable business lines. The workforce is spread across 70 countries, supporting an international client base. The model depends on international delivery and the continued operation and modernization of client IT environments.
Company facts
Categories
Key statistics
Year to date −20.4% · Average volume (30d) 3.4M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior target | Target |
|---|---|---|---|---|
| Aug 3, 2026 | Morgan Stanley | Target | $22 | $12 |
| Jul 31, 2026 | Stifel Nicolaus | Target | $12 | $10.50 |
| Jun 12, 2026 | RBC Capital | Target | $20 | $16 |
| May 8, 2026 | Stifel Nicolaus | Target | $19 | $12 |
| Jan 30, 2026 | Wolfe Research | Target | $13 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q1 FY27 | $0.41 | $0.40 | −3.3% | $2.99B | $3.00B | +0.5% | 0.00% |
| May 7, 2026Q4 FY26 | $0.70 | $0.77 | +9.4% | $3.17B | $3.13B | −1.4% | −21.48% |
| Jan 29, 2026Q3 FY26 | $0.83 | $0.96 | +15.5% | $3.18B | $3.19B | +0.6% | +0.14% |
| Oct 30, 2025Q2 FY26 | $0.71 | $0.84 | +18.3% | $3.17B | $3.16B | −0.4% | +9.74% |
Financial highlights
| 12 quarters | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.17B | $3.16B | $3.16B | $3.19B | $3.13B | $3.00B | |
| Gross profit | $768.0M | $771.0M | $483.0M | $759.0M | −$142.0M | $611.0M | |
| Operating income | $329.0M | $73.0M | $118.0M | $156.0M | −$89.0M | $241.0M | |
| Net income | $264.0M | $16.0M | $36.0M | $107.0M | −$141.0M | $122.0M | |
| Diluted EPS | $1.43 | $0.09 | $0.20 | $0.59 | −$0.78 | $0.73 | |
| Gross margin | 24.2% | 24.4% | 15.3% | 23.8% | -4.5% | 20.4% | |
| Operating margin | 10.4% | 2.3% | 3.7% | 4.9% | -2.8% | 8.0% |
Fiscal years (4-quarter sums)FY22 $16.27B · FY23 $14.43B · FY24 $13.15B · FY25 $12.87B · FY26 $12.64B
Revenue by product · Q1 FY27
Revenue by geography · Q1 FY27
Balance sheet, Jun 30, 2026Cash & short-term investments $1.96B · Total debt $4.17B · Total assets $12.93B · Shareholders' equity $3.06B
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 162.08M · Float 158.66M · 97.9% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 28.28M | 17.45% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 13.23M | 8.17% | 13F | Aug 13, 2026 |
| American Century Companies Inc | 10.44M | 6.44% | 13F | Aug 12, 2026 |
| Stowers Institute for Medical Research | 9.07M | 5.40% | 13G | May 1, 2026 |
| Glenview Capital Management, LLC | 8.90M | 5.20% | 13G | Mar 27, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 11, 2026 | Raul J. Fernandez | director, officer: President and CEO | +28,051 | $8.90 |
| Feb 2, 2026 | Raul J. Fernandez | director, officer: President and CEO | +16,446 | $15.24 |
| Dec 11, 2025 | Christopher Anthony Voci | officer: SVP, Controller and PAO | −2,500 | $15.15 |
| Sep 11, 2025 | Christopher Anthony Voci | officer: SVP, Controller and PAO | −2,500 | $14.52 |
Peers
- Accenture
Consulting, technology and managed-services overlap at scale
- IBM
Consulting, hybrid-cloud and application-operations overlap
- Kyndryl
Direct overlap in mission-critical IT infrastructure services
- Cognizant Technology Solutions
Enterprise technology services and AI-led transformation overlap
- Infosys (ADR)
AI-first business consulting and technology-services overlap
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| DXC Technology | $11.21 | +0.04% | $1.82B | 15.1 | 4.1 | 0.1 | −5.1% |
| Accenture | $189.20 | −0.17% | $116.03B | 15.1 | 13.2 | 1.6 | +5.6% |
| IBM | $235.80 | +0.10% | $221.96B | 20.8 | 18.4 | 3.2 | +1.1% |
| Kyndryl | $13.20 | 0.00% | $2.91B | 9.0 | 5.3 | 0.1 | −3.3% |
| Cognizant Technology Solutions | $64.12 | +0.11% | $28.85B | 13.8 | 10.6 | 1.3 | +4.5% |
| Infosys (ADR) | $12.01 | −0.41% | $48.89B | 14.9 | 14.8 | 2.4 | +1.0% |
| Median | 14.9 | 13.2 | 1.6 | +1.1% |